Global Biopharmaceuticals Market is Estimated to Reach $405 Billion by 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Biopharmaceuticals Market is Estimated to Reach $405 Billion by 2024

Description:

Global Biopharmaceuticals Market is estimated to reach $405 billion by 2024; growing at a CAGR of 9.3% from 2016 to 2024. – PowerPoint PPT presentation

Number of Views:41

less

Transcript and Presenter's Notes

Title: Global Biopharmaceuticals Market is Estimated to Reach $405 Billion by 2024


1
Global Biopharmaceuticals Market Is Estimated To
Reach 405 Billion By 2024
Manoj Kumkar SEO
Analyst help_at_variantmarketresearch.com
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
2
DESCRIPTION - Biopharmaceuticals Market
Global Biopharmaceuticals Market is estimated to
reach 405 billion by 2024 growing at a CAGR of
9.3 from 2016 to 2024. Biopharmaceuticals are
medical drugs produced by the means of
biotechnology methods comprising recombinant DNA
techniques, purification processes, and hybridoma
techniques. A potentially provocative technique
of producing biopharmaceuticals involves
transgenic organisms, mainly plants and animals,
that have been genetically improved to produce
drugs. They are proteins in nature including
antibodies and nucleic acids (DNA, RNA or
antisense oligonucleotides) used for vivo
diagnostic purpose and therapeutic.
Biopharmaceuticals are used in the treatment of
several chronic diseases such as metabolic,
neurological, cardiovascular, cancer, and other
intermittent diseases for which there remain no
available treatments. Complete Browse Report _at_
https//www.variantmarketresearch.com/report-categ
ories/pharmaceuticals/biopharmaceuticals-market
  
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
3
Global Biopharmaceuticals Market Size And Forecast
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
4
Biopharmaceuticals Market
The global biopharmaceuticals market has been
segmented into type, therapeutic application, and
geography. By type, it is segmented into
monoclonal antibodies, recombinant proteins,
granulocyte colony-stimulating factor (G-CSF),
interferon, recombinant human insulin,
erythropoietin, vaccines, growth hormones,
purified proteins, and others. Therapeutic
application is further bifurcated into oncology,
inflammatory infectious diseases, metabolic
disorders, cardiovascular diseases, and
others. Get Sample Report _at_ https//www.variantma
rketresearch.com/report-categories/pharmaceuticals
/biopharmaceuticals-market/sample-request
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
5
Global Biopharmaceuticals Market Share By Region
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
6
Major Key Players
  • Roche Holding AG
  • Bayer AG
  • Abbott Laboratories
  • Biocon Ltd
  • Eli Lilly and Company
  • Ranbaxy Laboratories Ltd.
  • Pfizer Inc.
  • Novartis AG
  • Genentech Inc.
  • Johnson Johnson Inc

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
7
The Key Takeaways From The Report
  • The report will provide detailed analysis of
    Biopharmaceuticals Market with respect to major
    segments such as type, therapeutic application,
    and geography
  • The report will include the qualitative and
    quantitative analysis with market estimation over
    2015-2024 and compound annual growth rate (CAGR)
    between 2016 and 2024
  • Comprehensive analysis of market dynamics
    including factors and opportunities will be
    provided in the report
  • An exhaustive regional analysis of
    Biopharmaceuticals Market has been included in
    the report
  • Profile of the key players of the
    Biopharmaceuticals Market will be provided, which
    include key financials, product services, new
    developments and business strategies

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
8
Scope Of Biopharmaceuticals Market
  • Type Segments
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • (G-CSF)
  • Interferon
  • Recombinant Human Insulin
  • Erythropoietin
  • Vaccines
  • Growth Hormones
  • Purified Proteins
  • Other Types
  • Therapeutic Application segments
  • Oncology
  • Inflammatory Infectious Diseases
  • Metabolic Disorders
  • Cardiovascular Diseases
  • Other Therapeutic Applications

sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
9
Table Of Content
Chapter 1 Prefix 1.1 Market Scope 1.2
Report Description 1.3 Research Methodology
1.3.1 Primary Research 1.3.2
Secondary Research 1.3.3 In-house Data
Modeling Chapter 2 Executive Summary
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
10
Table Of Content
Chapter 3 Market Outline 3.1 Market
Inclination, Trend, Outlook and Viewpoint 3.2
Market Share Analysis Companys Competitive
Scenario 3.3 Value Chain Analysis 3.4
Market Dynamics 3.4.1 Drivers
3.4.1.1 Impact Analysis 3.4.2
Restraints 3.4.2.1 Impact
Analysis 3.4.3 Opportunities 3.5
Porters five forces analysis 3.5.1
Factors Impact Analysis ..
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
11
Table Of Content
Chapter 7 Company Profiles 7.1 Roche Holding
AG 7.2 Bayer AG 7.3 Abbott Laboratories
7.4 Biocon Ltd 7.5 Eli Lilly and Company
7.6 Ranbaxy Laboratories Ltd. 7.7 Pfizer
Inc. 7.8 Novartis AG 7.9 Genentech, Inc.
7.10 Johnson Johnson, Inc
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
12
CONTACT US
VARIANT MARKET RESEARCH LLP Website
https//www.Variantmarketresearch.Com
Address 649 Mission St., 5th Floor, San
Francisco, CA 94105, United States. Tel
1-415-680-2785 Fax 1-415-680-2786 Email
help_at_variantmarketresearch.com
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
13
THANK YOU..
FOLLOW US
Sample request
Linked in
Google Plus
Twitter
Facebook
sales_at_variantmarketresearch.com
help_at_variantmarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com